PRU
54
7
FRT
58
-5
FSLR
78
8
DD
67
11
FOXA
38
3
ETN
83
4
TEL
75
4
PNW
57
-9
YUM
56
2
WBA
28
4
WM
70
2
ROK
43
4
BBY
48
5
SYF
97
2
DGX
48
4
UAL
56
2
SCHW
61
3
PAYX
47
6
IP
40
4
EIX
58
2
PRU
54
7
FRT
58
-5
FSLR
78
8
DD
67
11
FOXA
38
3
ETN
83
4
TEL
75
4
PNW
57
-9
YUM
56
2
WBA
28
4
WM
70
2
ROK
43
4
BBY
48
5
SYF
97
2
DGX
48
4
UAL
56
2
SCHW
61
3
PAYX
47
6
IP
40
4
EIX
58
2
Financhill
Back

VitaSpring Biomedical 10K Form

Buy
62

VSBC
VitaSpring Biomedical

Last Price:
16.00
Seasonality Move:
90.72%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive VSBC News And Ratings

See the #1 stock for the next 7 days that we like better than VSBC

VSBC Financial Statistics

Sales & Book Value

Annual Sales: $5.61M
Cash Flow: $0
Price / Cash Flow: 0
Annual Sales: $0.01
Price / Book: 0

Profitability

EPS (TTM): 0.00450
Net Income (TTM): $935.9K
Gross Margin: $2.07M
Return on Equity: 0%
Return on Assets: 0%

VitaSpring Biomedical Earnings Forecast

Key VitaSpring Biomedical Financial Ratios

  • The Gross Profit Margin over the past 6 years for VSBC is 36.84%.
  • The Selling, General & Administrative Expenses for VSBC have been equal to 10.14% of Gross Profit Margin.
  • The Net Earning history of VSBC is 22.52% of Total Revenues.
  • Per Share Earnings over the last 6 years have been positive in 2 years.

VitaSpring Biomedical Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: OTCM
Current Symbol: VSBC
Website: vitaspringbio.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 0
Quick Ratio: 0

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

VSBC Technical Analysis vs Fundamental Analysis

Buy
62
VitaSpring Biomedical (VSBC) is a Buy

Is VitaSpring Biomedical a Buy or a Sell?